Biofrontera Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$77.00K.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.22M, a 644.20% decline year-over-year.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $1.54M, a 778.29% increase year-over-year.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $236.00K.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.73M, a 1125.53% increase from fiscal 2024.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $141.00K.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$174.00K.
- Biofrontera Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$4.15M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.30M 10-Q · filed 2026-08-13 | $241.00K derived: sum of 3 quarters · filed 2026-08-13 | $477.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$1.22M 10-Q · filed 2026-05-14 | $318.00K derived: sum of 2 quarters · filed 2026-05-14 | $554.00K derived: sum of 3 quarters · filed 2026-05-14 | $285.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.77M derived: sum of 2 quarters · filed 2026-03-19 | $1.50M derived: sum of 3 quarters · filed 2026-08-13 | $1.73M 10-K · filed 2026-03-19 |
| 2025-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$33.00K derived: sum of 2 quarters · filed 2026-08-13 | $191.00K 10-Q · filed 2025-11-12 | $366.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$269.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$45.00K 10-Q · filed 2026-08-13 | $130.00K derived: sum of 3 quarters · filed 2026-08-13 | $68.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $224.00K 10-Q · filed 2026-05-14 | $399.00K derived: sum of 2 quarters · filed 2026-05-14 | $337.00K derived: sum of 3 quarters · filed 2026-05-14 | $246.00K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $113.00K derived: sum of 2 quarters · filed 2026-03-19 | $22.00K derived: sum of 3 quarters · filed 2026-03-19 | $141.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$153.00K derived: sum of 2 quarters · filed 2025-11-12 | -$34.00K 10-Q · filed 2025-11-12 | $139.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $28.00K 10-Q · filed 2025-08-13 | $201.00K derived: sum of 3 quarters · filed 2025-08-13 | -$448.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $119.00K 10-Q · filed 2025-05-15 | $292.00K derived: sum of 2 quarters · filed 2025-05-15 | -$357.00K derived: sum of 3 quarters · filed 2025-05-15 | -$885.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$476.00K derived: sum of 2 quarters · filed 2025-03-20 | -$1.00M derived: sum of 3 quarters · filed 2025-03-20 | -$174.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$649.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$1.18M derived: sum of 2 quarters · filed 2024-11-14 | -$347.00K 10-Q · filed 2024-11-14 | -$380.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$528.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $302.00K 10-Q · filed 2024-08-14 | $269.00K derived: sum of 3 quarters · filed 2024-08-14 | -$154.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $830.00K 10-Q · filed 2024-05-15 | $797.00K derived: sum of 2 quarters · filed 2024-05-15 | $374.00K derived: sum of 3 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | -$456.00K derived: sum of 2 quarters · filed 2024-03-15 | -$4.15M 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$423.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$4.12M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$3.70M 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |